Top
POLL POSITION
What Are You Watching In April 2018
 
pollcode.com free polls
QUICK HITS

• Through the first two weekends of the NBA Playoffs, national ad spend has reached $135.1 million across league media partners: TNT, ESPN, ESPN 2, ABC and NBA TV, according to iSpot.TV.  That is down from $145 million at the same point a year ago. Leading brands are Burger King (232 spots), Taco Bell (197), Verizon (158), Gatorade (157) and Corona Extra (147).

• NBC Sports said its coverage of the 2018 NHL Stanley Cup Playoffs across the networks of NBCUniversal is averaging a Total Audience Delivery of 751,000 viewers through Sunday, the best in four years through the first 12 days of the playoffs. Coverage on NBC is the best since 2015, while cable coverage on NBCSN is the best in six years. Live streaming of the first 12 days of the Stanley Cup Playoffs has set records in all key metrics.

• Olympic Gold Medalist and 4-time World Championship cross-country skiing medalist Jessie Diggins has signed with Ross-Simons jewelers. According to Diggins, “Fabulous jewelry at great values is what Ross-Simons is all about, and I believe in the sincerity of that message.

KEEPING SCORE

Top Selling NBA Footwear
1. LeBron James Nike
2. Under Armour Footwear
3. Chris Paul Nike Jordan
4. Kevin Durant Nike
5. Converse Shoes
6. Slide Sandals
7. Carmelo Anthony Nike Jordan
8. Stephen Curry Under Armour
9. Jordan Shoes
10. Stance Socks

SOURCE Store.NBA.com

BUY SELL

WEEKEND BOX OFFICE (April 20-22)
1. A Quiet Place $22M
2. Rampage $21M
3. I Feel Pretty $16.2M
4. Super Troopers 2 $14.7M
5. Blumhouse's Truth or Dare $7.9M
6. Ready Player One $7.5M
7. Blockers $6.9M
8. Black Panther $4.6M
9. Traffik $3.9M
10. Isle of Dogs $3.4M
SOURCE COMSCORE

SEARCH

NYSportsJournalism.com + Topic Of Requested Search

NFL Draft: Fox, NFL Net See More Ads Below

COLLEGE

CFB Title Games '21-24
No. 1 Colleges Since '92
NCAA: More Health $$$
Cancer Drives Home
NCAA Reballs Madness

Let us not seek the Republican answer or the Democratic answer, but the right answer. Let us not seek to fix the blame for the past. Let us accept our own responsibility for the future.
Read more at http://www.brainyquote.com/quotes/quotes/j/johnfkenn121400.html#46Ul8rBF4XpB4lo0.99
Let us not seek the Republican answer or the Democratic answer, but the right answer. Let us not seek to fix the blame for the past. Let us accept our own responsibility for the future.
Read more at http://www.brainyquote.com/quotes/quotes/j/johnfkenn121400.html#JZxA5jXY4rCwemgZ.99
Let us not seek the Republican answer or the Democratic answer, but the right answer. Let us not seek to fix the blame for the past. Let us accept our own responsibility for the future.
Read more at http://www.brainyquote.com/quotes/quotes/j/johnfkenn121400.html#JZxA5jXY4rCwemgZ.99
Let us not seek the Republican answer or the Democratic answer, but the right answer. Let us not seek to fix the blame for the past. Let us accept our own responsibility for the future.
Read more at http://www.brainyquote.com/quotes/quotes/j/johnfkenn121400.html#46Ul8rBF4XpB4lo0.99
Tuesday
Mar082016

Sharapova Faults For Using Banned Drug, Waits For Tennis Ban To Be Served  

By Barry Janoff

March 7, 2016: Stating that "I made a a huge mistake . . . I have to take full responsibility," tennis star Maria Sharapova said during a self-called press conference that she had received a letter from the International Tennis Federation telling her she had failed a drug test during the Australian Open.

Sharapova, ranked No. 7 in the world, said that the failed drug test was for anti-ischemic drug Mildronate, also known as meldonium, used to counteract a lack of blood flow.

The visibly shaken but stoic Sharapova said that she had been taking the drug "for ten years."

ITF said late last year it would be adding meldonium to its list of banned drugs via a change in policy that officially took affect Jan. 1.

The Australian Open was played Jan. 18-31. Sharapova lost in the quarter-finals of that Grand Slam to Serena Williams.

Sharapova said that she received notification from the World Anti-Doping Agency on Dec. 22 that the drug would be banned beginning Jan. 1.

"I received an e-mail on 22 December from WADA about the changes happening to the banned list and you can see prohibited items . . . I didn't click on that link."

According to Sharapova, she "continued to take it (because) it made me feel healthy."

Sharapova said that she used the drug as prescribed by a doctor since 2006 because she was “getting sick very often, and I had a magnesium deficiency. I also had an irregular EKG results, and I have a family history of diabetes.”

According to Sharapova, "I have to take full responsibility for it. It's my body and I have to be responsible for what I put in my body.

"I have been very open and honest about many things, I take great responsibility in my job . . . I made a huge mistake."

The impact could be far-reaching for Sharapova, her career, her marketing partners, her fans and for tennis. She is the highest-paid female athlete in the world, topping $23 million in endorsements alone, according to Forbes.

A played found to use a banned drug could be suspended for upward of four years. In this case, Sharapova might receive a two-year ban due to mitigating circumstances, according to industry analysts.

Sharapova's endorsements include Nike, Porsche, Evian, Tag Heuer, Avon and Head. She also has other off-the-court income from such investments as candy company Sugarpova, which she founded.

(Editor's note: Tag Heuer said it would not continue discussions to renew its contract with the tennis player, which the company said expired at the end of 2015; both Nike and Porsche said they would "suspend" or "postpone" activiations with her, but did not end their contracts with her.)

Her actions would also affect marketing partners and sponsors of the WTA, other tennis groups and tournaments and, this year, partners of the Summer Olympics in Rio, where she was expected to represent her native Russia.

Sharapova, a five-time Grand Slam winner, played sporadically toward the end of last year, including missing the U.S. Open Grand Slam due to injuries and has not played competitively since the Australian Open.

According to a statement from WADA, "On 26 January 2016, Ms Sharapova provided an anti-doping sample to the TADP (Tennis Anti-Doping Program) in association with her participation in the 2016 Australian Open.

"That sample was analyzed by a World Anti-Doping Agency accredited laboratory, which returned a positive for meldonium, which is a prohibited substance under the WADA Code and, therefore also the TADP.

"In accordance with Article 8.1.1 of the TADP, Ms Sharapova was charged on 2 March with an Anti-Doping Rule Violation.

"I know that with this I face consequences and I don't want to end my career this way and I hope that I will be given another chance to play this game."

"Ms Sharapova has accepted the finding of meldonium in her sample collected on 26 January.

"As meldonium is a non-specified substance under the WADA (and, therefore, TADP) list of Prohibited Substances and Prohibited Methods, Ms Sharapova will be provisionally suspended with effect from 12 March, pending determination of the case."

Many believed that she had called the press conference to reveal that she was retiring, much as NFL star Peyton Manning had done earlier in the day.

"I know many of you thought I'd be announcing my retirement," she said. "If I was ever going to announce my retirement, it would not be in a downtown Los Angeles hotel with a fairly ugly carpet."

On a more somber note, Sharapova said, "I know that with this I face consequences and I don't want to end my career this way and I hope that I will be given another chance to play this game again."

Back to Home Page